Corcept Therapeutics (CORT) Tops Q4 EPS by 3c; Issues Light FY16 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 80.68 -0.44 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.12 | 52 Week High | $10.00 | |||
| Open | $80.93 | 52 Week Low | $3.22 | |||
| Day High | $82.23 | P/E | N/A | |||
| Day Low | $80.01 | EPS | $-0.46 | |||
| Volume | 235,201 | |||||
